TABLE 5.

Number of participants with movement or positional impairments, urgency provoked with primary tests, and urgency relieved with secondary tests

	Participants Displaying an Impairmenta			Participants with Urgency Provoked with Primary Testb			Participants with Urgency Relieved with Secondary Testc
Movement/Positional Test	UFLUTSf n=21	Cong n=21	Ph	UFLUTSf n=21	Cong n=21	Ph	UFLUTSf n=21
Forward bend	15	10	<.21	2	0	0.49	3
Return from forward bend	12	4	0.03	5	0	0.05	4
Single leg stancee	21	10	<.01	0	0	0.99	3
Sidelyinge	21	12	<.01	3	1	0.61	11
	Participants Displaying a Positive Testd			Participants with Urgency Provoked during Testb
Additional Clinical Testse	UFLUTSf n=21	Cong n=21	Ph	UFLUTSf n=21	Cong n=21	Ph
FADIR	7	4	0.48	8	1	0.02
FABER	3	2	0.99	3	1	0.61
Stork test	17	6	<.01
Pubic symphysis palpation				16	5	<.01
Hip ROM	17	12	0.18
External Rotation ROM				2	0	0.50
Internal Rotation ROM				5	0	<.01

^aNumber of participants with any examiner-observed movement impairment in spine, pelvis or hip during primary test

^bNumber of participants who reported same or worse bladder urgency during primary test compared to baseline

^cNumber of participants who reported reduced bladder urgency with secondary test when compared to symptoms during the primary test

^dNumber of participants with positive test (see Table 4)

^eTest performed bilaterally, participants only counted once regardless of if the phenomena occurred bilaterally

^fParticipants with bothersome urgency and/or day/night frequency at least sometimes in the past 4 weeks

^gParticipants without urgency and frequency symptoms

^hP≤ .05, values from Fisher’s exact test